Talk:BIIB033

This is a duplicate page: BIIB033 is Opicinumab. (See http://www.biocentury.com/products/biib033)

Also note the stage II failure of this substance: http://investorplace.com/2016/06/biib-stock-biogen-opicinumab-failure-ms-treatment/

84.168.145.21 (talk) 22:40, 7 June 2016 (UTC)